Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001810326-21-000001
Filing Date
2021-04-13
Accepted
2021-04-13 17:08:25
Documents
1
Effectiveness Date
2021-04-13
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6020
  Complete submission text file 0001810326-21-000001.txt   7179
Mailing Address 139 MAIN STREET, SUITE 401 CAMBRIDGE MA 02142
Business Address 139 MAIN STREET, SUITE 401 CAMBRIDGE MA 02142 6172765578
MISSION BIOCAPITAL V LP (Filer) CIK: 0001810326 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-366421 | Film No.: 21823645